Minimum quality criteria are needed in the assessment and communication of unexpected drug safety findings of marketed products from RCTs Response
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. Bd. 74. H. 1. 2012 S. 209-210
Erscheinungsjahr: 2012
Publikationstyp: Zeitschriftenaufsatz
| Geprüft: | Bibliothek |
Autoren
Blot, K (Autor)
Michel, MC (Autor)
Klassifikation
DDC Sachgruppe:
Medizin
